AMRISC, LLC – Trademark Portfolio
Entity Type: 16
AMRISC, LLC holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 10 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 6 trademarks are registered and 4 are pending. Notable registered marks include AMRISC, W RISK, WELLINGTON, CHRONOS UNDERWRITERS, and WAYPOINT RISK MANAGERS. The owner is based in SPRING, TX.
1700 CITY PLAZA DRIVE, SUITE 200
SPRING, TX 77389
Showing of trademarks Trademarks
Trademark Classifications
AMRISC, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Advertising; business management; business administration; office functions
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does AMRISC, LLC have?
AMRISC, LLC has 11 U.S. trademarks filed with the USPTO. Of these, 6 registered, 4 pending, 1 abandoned.
What trademark classes does AMRISC, LLC file in?
AMRISC, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 35 (Advertising & Business), Class 9 (Computers & Electronics). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are AMRISC, LLC's most well-known trademarks?
AMRISC, LLC's registered trademark portfolio includes well-known marks such as AMRISC, W RISK, WELLINGTON, CHRONOS UNDERWRITERS, and WAYPOINT RISK MANAGERS. These are among 6 currently registered trademarks in the portfolio.
What is AMRISC, LLC's trademark registration success rate?
AMRISC, LLC has a 86% trademark registration rate, with 6 out of 7 resolved applications resulting in successful registration. Currently, 4 applications are pending review.